Cargando…
Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study
Introduction: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease with high symptom burden, of unknown etiology, with no established treatment. We observed patients with long-standing ME/CFS who got cancer, and who reported improvement of ME/CFS symptoms after chemotherapy inclu...
Autores principales: | Rekeland, Ingrid G., Fosså, Alexander, Lande, Asgeir, Ktoridou-Valen, Irini, Sørland, Kari, Holsen, Mari, Tronstad, Karl J., Risa, Kristin, Alme, Kine, Viken, Marte K., Lie, Benedicte A., Dahl, Olav, Mella, Olav, Fluge, Øystein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201056/ https://www.ncbi.nlm.nih.gov/pubmed/32411717 http://dx.doi.org/10.3389/fmed.2020.00162 |
Ejemplares similares
-
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
por: Rekeland, Ingrid G., et al.
Publicado: (2022) -
Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
por: Sørland, Kari, et al.
Publicado: (2021) -
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
por: Hoel, Fredrik, et al.
Publicado: (2021) -
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
por: Fluge, Øystein, et al.
Publicado: (2015) -
Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Lande, Asgeir, et al.
Publicado: (2020)